Global study zeroes in on vaping’s respiratory risks among exclusive e-cigarette users

The VERITAS study, a global cross-sectional survey, aims to isolate the effects of vaping on respiratory health by focusing exclusively on individuals who vape but have never smoked, offering unique insights into the direct consequences of e-cigarette use.

Exploring the current use and future of alternatives to traditional informed consent in acute stroke trials

The University of Cincinnati’s Yasmin Aziz, MD, and Joseph Broderick, MD, coauthored an editorial published Nov. 7 in the journal Neurology analyzing the current use

November 9, 2024

Inflammatix raises $57M to advance test for infection, sepsis

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Inflammatix raised $57 million to

September 13, 2024

The election is Tuesday. What’s at stake for the pharma industry?

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.